Back to top

Analyst Blog

Zacks Equity Research

DeVry Expands in Nursing Education

APOL DV

 ZacksTrade Now

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Diversified education provider DeVry Inc.’s (DV - Analyst Report) Chamberlain College of Nursing has recently entered into a collaboration with The Honor Society of Nursing of Sigma Theta Tau International – a non profit organization that works with nurses across the world – to establish the Center for Excellence in Nursing Education.
 
The Center for Excellence in Nursing Education will support nurse educators by offering career guidance, resources related to nursing education and Emerging Educational Administrator Program. The Center, with its volunteer advisory board of 10 nurse leaders, will design nursing programs to promote nursing education across the world.

The introduction of the nursing education model is in response to the growing demand for certified nurses. The Center for Excellence in Nursing Education intends to provide the necessary infrastructure and support in order to bridge the demand and supply gap in the number of trained nurses.

DeVry witnessed solid new enrollment growth in Chamberlain College of Nursing and in other institutions like Carrington Colleges in the first quarter of fiscal 2013, owing to strong demand for medical courses. Total enrollments increased 20.2% at the Chamberlain College of Nursing and 2.1% at DeVry Medical International. Medical and Healthcare segment revenue grew 7.4% year over year in the quarter, driven by solid new enrollment growth.

Continued progress on its performance improvement plan to align costs, enrollment growth and growth investments helped the company to deliver better-than-expected results in the first quarter of fiscal 2013. The first quarter results were a turnaround from the past few weak quarterly results, thus justifying the short-term buy rating.

DeVry, a peer of Apollo Group (APOL - Analyst Report), carries a Zacks #2 Rank in the near term (Buy rating). Currently, we have a Neutral recommendation on DeVry.

 

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
MODINE MANUF MOD 17.19 +9.21%
VERTEX ENERG VTNR 8.13 +8.98%
CLAYTON WILL CWEI 138.01 +5.72%
KNIGHTSBRIDG VLCCF 13.25 +5.66%
CANADIAN SOL CSIQ 30.83 +5.55%